160 related articles for article (PubMed ID: 20669228)
1. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.
Virtanen A; Anttila A; Luostarinen T; Nieminen P
Int J Cancer; 2011 Jun; 128(11):2681-7. PubMed ID: 20669228
[TBL] [Abstract][Full Text] [Related]
2. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.
Virtanen A; Nieminen P; Luostarinen T; Anttila A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1960-9. PubMed ID: 21752985
[TBL] [Abstract][Full Text] [Related]
3. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer.
Eaker S; Adami HO; Granath F; Wilander E; Sparén P
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907
[TBL] [Abstract][Full Text] [Related]
4. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
Virtanen A; Anttila A; Nieminen P
BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
[TBL] [Abstract][Full Text] [Related]
5. [Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].
Virtanen A; Nieminen P; Malila N; Luostarinen T; Anttila A
Duodecim; 2013; 129(16):1709-17. PubMed ID: 24069641
[TBL] [Abstract][Full Text] [Related]
6. Improving cervical cancer screening attendance in Finland.
Virtanen A; Anttila A; Luostarinen T; Malila N; Nieminen P
Int J Cancer; 2015 Mar; 136(6):E677-84. PubMed ID: 25178683
[TBL] [Abstract][Full Text] [Related]
7. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
8. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
9. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
[TBL] [Abstract][Full Text] [Related]
10. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
Jensen H; Svanholm H; Støvring H; Bro F
J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
[TBL] [Abstract][Full Text] [Related]
11. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
12. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.
Giorgi Rossi P; Fortunato C; Barbarino P; Boveri S; Caroli S; Del Mistro A; Ferro A; Giammaria C; Manfredi M; Moretto T; Pasquini A; Sideri M; Tufi MC; Cogo C; Altobelli E;
Br J Cancer; 2015 Feb; 112(4):667-75. PubMed ID: 25633037
[TBL] [Abstract][Full Text] [Related]
13. Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods.
Stein K; Lewendon G; Jenkins R; Davis C
J Med Screen; 2005; 12(4):185-9. PubMed ID: 16417695
[TBL] [Abstract][Full Text] [Related]
14. Can an appointment-letter intervention increase pap smear screening in Samliem, Khon Kaen, Thailand?
Chumworathayi B; Yuenyao P; Luanratanakorn S; Pattamadilok J; Chalapati W; Na-Nhongkai C
Asian Pac J Cancer Prev; 2007; 8(3):353-6. PubMed ID: 18159966
[TBL] [Abstract][Full Text] [Related]
15. Screening HMO women overdue for both mammograms and pap tests.
Valanis BG; Glasgow RE; Mullooly J; Vogt TM; Whitlock EP; Boles SM; Smith KS; Kimes TM
Prev Med; 2002 Jan; 34(1):40-50. PubMed ID: 11749095
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
Buehler SK; Parsons WL
CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
[TBL] [Abstract][Full Text] [Related]
17. Attitudes toward self-sampling for cervical cancer screening among primary care attendees living on the US-Mexico border.
Penaranda E; Molokwu J; Hernandez I; Salaiz R; Nguyen N; Byrd T; Shokar N
South Med J; 2014 Jul; 107(7):426-32. PubMed ID: 25010584
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates.
MacLaughlin KL; Swanson KM; Naessens JM; Angstman KB; Chaudhry R
J Eval Clin Pract; 2014 Apr; 20(2):136-43. PubMed ID: 24237657
[TBL] [Abstract][Full Text] [Related]
19. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
[TBL] [Abstract][Full Text] [Related]
20. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
